Post-approval studies (Phase 4)Study completedNCT01336569What this trial is testingSafety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on TimololWho this might be right forGlaucoma Alcon Research 50
Post-approval studies (Phase 4)Study completedNCT00759239What this trial is testingPhase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular HypertensionWho this might be right forOpen-angle GlaucomaOcular Hypertension Alcon Research 36